Source: Annual Congress 2003 - Mechanisms of epithelial cell activation I
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Krasnowska, M. Nittner-Marszalska, R. Krasnowski, W. Kopec, A. Fal (Wroclaw, Poland). Endothelin, endothelial cells and von Willenbrandt factor in peripheral blood in asthma patients. Eur Respir J 2003; 22: Suppl. 45, 582

Member's Comments

No comment yet.

Related content which might interest you: Response of plasma von Willebrand factor to systemic endothelial injury in pulmonary arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 545s Year: 2006 Circulating vascular endothelial growth factor and osteoporosis in patients with COPD Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Increased vascular endothelial growth factor (VEGF) secretion from activated T cells in COPD Source: Annual Congress 2007 - Cell-based tissue modulation: the good and the ugly? Year: 2007 Microalbuminuria and von Willebrand factor antigen (vWF) as markers of endothelial dysfunction in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 123s Year: 2004 Elevated Von Willebrand Factor expression in the activated pulmonary endothelium of chronic thromboembolic pulmonary hypertension patients enhances platelet adhesion. Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020 Distinct patterns of circulating endothelial cells in pulmonary hypertension Source: Eur Respir J 2010; 36: 1284-1293 Year: 2010 The influence of sera from interstitial lung diseases (ILD) patients on human mononuclear cells (MNC) production of vascular endothelial growth factor (VEGF) Source: Eur Respir J 2004; 24: Suppl. 48, 553s Year: 2004 Imbalance between vascular endothelial growth factor and endostatin in emphysema Source: Eur Respir J 2003 Oct 01;22(4):609-612 Year: 2003 Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients Source: Eur Respir J 2002; 20: Suppl. 38, 1s Year: 2002 Role of corticosteroids in TNFα-induced expression of vascular endothelial growth factor (VEGF) in human airway smooth muscle cells Source: Annual Congress 2003 - Cell signalling and cytokines in asthma Year: 2003 Expression of platelet derived-growth factor (PDGF) in remodelled pulmonary arteries of COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 25s Year: 2002 A comparative study of two angiogenic factors: vascular endothelial growth factor (VEGF) and angiogenin (Ang) in induced sputum from asthmatic children in acute attack Source: Eur Respir J 2006; 28: Suppl. 50, 258s Year: 2006 Effects of training on endothelial function and circulating endothelial progenitor cells in COPD patients Source: Annual Congress 2008 - Pulmonary hypertension I Year: 2008 Circulating endothelial progenitor cells in COPD: effect of pulmonary hypertension Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension Year: 2007 Vascular endothelial growth factor (VEGF) levels in induced sputum and plasma in asymptomatic and COPD smokers. Correlation with airway and systemic inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 652s Year: 2006 Vascular endothelial growth factor (VEGF) and airway inflammation in COPD. Correlation with pulmonary function Source: Eur Respir J 2006; 28: Suppl. 50, 653s Year: 2006 Circulating endothelial progenitor cells and CD45+ cells in pulmonary arteries of COPD patients Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010 Imbalance between circulating endothelial cells and endothelial progenitors in idiopathic pulmonary fibrosis Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011 Circulating fibrocytes are increased in children and young adults with pulmonary hypertension Source: Eur Respir J 2012; 39: 104-111 Year: 2012 Circulating fibrocytes are increased in children and young adults with pulmonary hypertension Source: Eur Respir J 2011; 39: 104-111 Year: 2012